Editorial Comment on “The Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well‐Treated Major Depressive Disorder Experiencing SSRI‐Induced Sexual Dysfunction”

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 10, 2015-10 ,pp. : 2049-2050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

By Wu Eric   Greenberg Paul   Yang Elaine   Yu Andrew   Ben-Hamadi Rym   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2805-2813

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram in the treatment of major depressive disorder: A meta-analysis

By Kennedy Sidney H.   Andersen Henning F.   Thase Michael E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 161-175

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder

By Mahableshwarkar Atul R.   Jacobsen Paula L.   Chen Yinzhong  

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 217-226

Informa Healthcare

Access to resources Recommend Favorite

Increased Serotonin Receptor 1A Binding in Major Depressive Disorder after Psychotherapy, but Not after SSRI Pharmacotherapy, Is Related to Improved Social Functioning Capacity

By  

Psychotherapy and Psychosomatics, Vol. 82, Iss. 4, 2013-06 ,pp. : 260-261

Karger

Access to resources Recommend Favorite